Timing ovulation for intrauterine insemination with a GnRH antagonist

Human Reproduction

Volumn 20, Issue 2, 2005, Pages 368-372

  Gomez Palomares J L ^a   Juliia B ^b   Acevedo Martin B ^a   Martinez Burgos M ^a   Hernandez E R ^a   Ricciarelli, E ^a  

^a Clinica Medicina Reprod/Ginecologia   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

GnRH antagonist; Intrauterine insemination; Pregnancy rates

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INTRAUTERINE INSEMINATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE PREGNANCY; OVARY FOLLICLE MATURATION; OVULATION INDUCTION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 14044250916     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh602     Document Type: Article

References (23)

1. Acevedo-Martin B, Sanchez M, Gomez-Palomares JL, Cuadros J, Ricciarelli E and Hernández ER (2004) LH-supplementation increased pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril 82,343-347.
2. Claman P (2004) Simplifying superovulation and intrauterine insemination treatment: evidence and clinical decision making. Fertil Steril 82, 32-33.
3. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH and Pyrzak R (2001) Relationship of follicle numbers and estradiol levels to multiple implantation in 3,608 intrauterine insemination cycles. Fertil Steril 75, 69-78.
4. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH and Pyrzak R (2002) Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril 78,1088-1095.
5. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, Krebs D and Klingmuller D (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9,788-791.
6. Duran HE, Morshedi M, Kruger T and Oehninger S (2002) Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update 8,373-384.
7. European and Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16, 644-651.
8. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT, Jr, Schoolcraft W and Shapiro DB (2001) North American Ganirelix Study Group Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 75,38-45.
9. Frydman R, Cornel C, de Ziegler D, Taieb J, Spitz IM and Bouchard P (1991) Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil Steril 56,923-927.
10. Ghosh C, Buck G, Priore R, Wacktawski-Wende J and Severino M (2003) Follicular response and pregnancy among infertile women undergoing ovulation induction and intrauterine insemination. Fertil Steril 80, 328-335.
11. Hernández ER (2000) Embryo implantation and GnRH antagonists: embryo implantation, the Rubicon for GnRH antagonists. Hum Reprod 15, 1211-1216.
12. Houmard BS, Juang MP, Soules MR and Fujimoto VY (2002) Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment. Fertil Steril 77,384-386.
13. Kaplan PF, Katz SL, Thompson AK and Freund RD (2002) Cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination. Influence of the number of mature follicles at hCG administration. J Reprod Med 47,35-39.
14. Khalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S and Westergaard LG (2001) Homologous intrauterine insemination. An evaluation of prognostic factors based on a review of 2473 cycles.Acta Obstet Gynecol Scand 80,74-81.
15. Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC and Devroey P (2003) Abnormal endometrial development occurs during the luteal phase of non supplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 80,464-466.
16. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L and Martikainen H (1999) Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 14,698-703.
17. Olivennes F, Cunha-Filho IS, Fanchin R, Bouchard P and Frydman R (2002) The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 8,279-290.
18. Osuna C, Matorras R, Pijoan JI and Rodríguez-Escudero J (2004) One versus two inseminations per cycle in intrauterine insemination with sperm from patients' husbands: a systematic review of the literature. Fertil Steril 82, 17-24.
19. Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G and Crosignani PG (2001) Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod 16,2258-2262.
20. Ragni G, Somigliana E and Vegetti W (2004) Timing of intrauterine insemination: where are we? Fertil Steril 82,25-26.
21. Reissmann T, Felberbaum R, Diedrich K, Engel J, Comaru-Schally AM and Schally AV (1995) Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Hum Reprod 10,1974-1981.
22. Ricciarelli E, Sánchez M, Martínez M, Andrés L, Cuadros J and Hernández ER (2003) Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles. Fertil Steril 79,1461-1463.
23. Tur R, Barri PN, Coroleu B, Buxaderas R, Martínez F and Balasch J (2001) Risk factors for high-order multiple implantation after ovarian stimulation with gonadotropins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Hum Reprod 16,2124-2129.